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We have generated transgenic mice carrying the URR
of the human papillomavirus type 11 ligated in front
of the Escherichia coli b-galactosidase coding region
sequence. Using X-Gal staining to demonstrate
b-galactosidase production, we observed a hair-specific
transcription of the reporter gene. This transcription
was limited to the epithelial cells of the hair bulge
region. The transgene was developmentally regulated,
Human papillomaviruses (HPV) are epitheliotropicsmall tumor viruses with a circular double-strandedDNA genome of µ8 kb. More than 90 differentHPV types have so far been identified, some ofwhich are preferentially associated with benign
lesions (low-risk type, such as types 1, 6, and 11) whereas others
are found mainly in association with malignant tumors (high-risk
type, such as types 16, 18, and 33). The low-risk type HPV11 is
described to infect the mucosa of the organs of the genital tract
and the perianal area, although viral sequences have also been
detected in cervical neoplasias and laryngeal papillomas (Dartmann
et al, 1986; Henderson et al, 1987; Guillou et al, 1991; Shen
et al, 1996).
Initiation of transcription of all HPV early genes takes place
preferentially at the upstream regulatory region or URR (an E7
internal promoter has also been described), which contains binding
elements for cellular as well as viral regulatory proteins (Chan et al,
1989; Thierry et al, 1992; Thierry, 1993). As in the case with other
HPV types, the URR sequence of HPV11 contains promoter and
enhancer properties (Auborn et al, 1989; Auborn and Steinberg,
1991; Hoppe-Seyler and Butz, 1994). The promoter region has
been found to enclose two well defined functional regions, CEI
and CEII, which are responsible for a cell-specific expression
(Dollard et al, 1993). In addition, it appears that HPV11 lacks the
octamer-binding site found in the high-risk types (Morris et al,
1993) and it has been shown that C/EBPβ transcription factor acts
as a negative regulator in HPV11 (Wang et al, 1996). Putative
binding sites for AP-1, SP1, and NF1 have also been described
(Dollard et al, 1993). Interestingly, viral transcription in cultured
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as no LacZ staining was demonstrated during embryo-
genesis and specific staining was first observed after
birth. Surprisingly, dexamethasone and ultraviolet B,
but not phorbol myristate acetate or progesterone
treatment of the animals resulted in an increase in
number and intensity of hair follicles expressing the
reporter gene. Key words: promoter/skin/transcription. J
Invest Dermatol 112:893–898, 1999
cells derived from laryngeal papillomas carrying HPV11 sequences
can be modulated by various agents such as calcium or retinoic
acid (DiLorenzo and Steinberg, 1995). Thus, although the general
structure of the URR follows the rules of all other HPV types,
specific differences in this region suggest that HPV11 regulates
transcription by mechanisms different to the known high-risk
HPV types.
Little is known about the control mechanisms regulating the
transcription of HPV sequences in vivo. To date, only mice
transgenic for high-risk HPV-URR sequences have been investi-
gated and no data have been published concerning the low-risk
types (Choo et al, 1992; Cid et al, 1993; Chen et al, 1995; Michelin
et al, 1997). The aim of this work, therefore, was to investigate
the transcriptional regulation of the HPV11-URR sequences in
transgenic mice. Animals were generated carrying the LacZ coding
sequence under the control of the URR region of the HPV type
11. Analysis of the transgenic animals obtained demonstrated a tight
and specific transcriptional pattern of the transgene to the hair
bulge epithelial cells. Most interestingly, HPV11-URR-dependent
gene expression can be modulated by treatment with glucocorticoids
or ultraviolet (UV) light, making these animals a valuable tool to
study the effects of environmental noxae on the transcriptional
characteristics of low-risk HPV types.
MATERIALS AND METHODS
Cloning procedure The bacterial lacZ gene was cloned into the HindIII/
HincII site of the BlueScript KS-vector. The BamHI/BsmI URR fragment
was isolated from a plasmid containing the complete HPV11 genome
cloned into pBR322 and introduced into the XbaI site of the BlueScript-
lacZ vector by blunt end ligation. The DNA of the resulting recombinant
HPV11-URR/β-gal plasmid was sequenced to verify orientation of the
URR (Fig 1).
Generation and identification of transgenic mice The NotI/ApaI
fragment of the recombinant plasmid, containing the HPV11-URR and
β galactosidase reporter gene (Fig 1), was isolated by agarose gel electro-
phoresis, purified, and used for microinjection into pronuclei of zygotes
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Figure 1. Schematic representation of the recombinant used for
the production of transgenic animals. The BamHI–BsmI fragment of
the HPV11 DNA (1071 base pairs) was cloned in front of the bacterial
lacZ gene (3.8 kb) in the plasmid pBluescript KS. The 5 kb long NotI–
ApaI fragment was excised from the plasmid, isolated and used for the
generation of transgenic mice.
generated from F1 hybrid female mice (C57Bl6xDBA/2) mated to DBA/
2 males. Surviving one- or two-cell embryos were transferred into the
oviducts of pseudopregnant foster mice according to published methods
(Hogan et al, 1986).
Tail biopsies were taken and digested overnight in 800 µl of ‘tail-buffer’
[50 mM Tris pH 8.0, 100 mM EDTA, 100 mM NaCl, 1% (wt/vol) sodium
dodecyl sulfate, 0.5 mg per ml proteinase K] at 55°C. After protein
precipitation with salt, the DNA was precipitated with isopropanol, washed,
digested with restriction enzymes, and separated on agarose gels. Southern
blots were hybridized at 65°C with a 32P-radiolabeled URR fragment.
Washing steps were performed at 65°C for 15 min with 0.2 3 sodium
citrate/chloride buffer and 0.2% sodium dodecyl sulfate.
Treatment of animals To avoid an irritation of the skin, the back of
the mice was shaved using an electrical shaver 24 h prior to treatment.
Dexamethasone was dissolved in acetone at a concentration of 2.5 mg per
ml and 50 µl of this solution were spotted on to the back of the mice.
The same amount of solvent was spotted elsewhere onto the same animal
as control. Animals were killed 6, 24, 48, and 72 h after dexamethasone
treatment and biopsies of the spots were taken, frozen and used for X-Gal
staining. For UVB treatment (UVB lamp of a wavelength 280–320 nm)
narcotized animals were covered with a sheet leaving only two windows
of 1 cm2 uncovered. Irradiation was at a dose of 2 W per cm2 At 8, 16,
24, and 48 h after irradiation, skin biopsies were taken for analysis. For
quantitation, at least 100 follicles were counted in every slide and at least
three slides were counted per transgenic mouse. A total of 10 animals was
used for each experiment and each experiment was repeated at least
two times.
Treatment with proteolytic enzymes was performed by iontophoresis or
via lipid vehicles as described (Protopapa, 1997); briefly, anesthetized mice
were depilated using warm wax and proteolytic enzymes (1 mg per ml of
chymotrypsin and papain) were applied to the skin using an electrode at
2 mA for 2 min. Alternatively, the enzymes were packaged into liposomes
and rubbed twice within 48 h on to the depilated skin of mice for 8 min.
X-Gal staining Mice were killed and the organs were dipped into
cooled isopentane, frozen, and conserved in liquid nitrogen. Cryosections
of 6–10 µm were performed in a cryostat at –20°C and transferred to
clean, 3-aminopropyltriethoxysilane dissolved in acetone (Sigma, Munich,
Germany) coated glass slides. The samples were fixed for 5 min at 4°C in
2% paraformaldehyde, 0.2% glutaraldehyde, 0.02% NP-40, 0.01% sodium
dodecyl sulfate in phosphate-buffered saline, and then washed in phosphate-
buffered saline again. The slides were covered with 600 µl reaction mix
(1 mg per ml X-Gal [5-bromo-4-chloro-3 indolyl-β-D-galctopyranoside],
5 mM K3Fe[CN]6, 5 mM K4Fe[CN]6 and 2 mM MgCl2 in phosphate-
buffered saline [0.14 M NaCl, 0.003 M KCl, 1.5 mM KH2PO4, 8 mM
Na2HPO4]) in the dark, in a humidity chamber overnight at 37°C and
then rinsed in phosphate-buffered saline. Slides were counterstained with
hematoxylin–eosin.
Other methods Transfections were performed in HaCaT cells using
poly L-ornithine as described (Nead and McCance, 1995). Forty-eight
hours after addition of the DNA, cell extracts were prepared and the
β-galactosidase activity was measured using chlorophenol red-β-D-galacto-
pyranoside as chromogen. For RNA isolation, deep frozen organs were
pulverized in a mortar under liquid nitrogen and the RNA was extracted
using the RNeasy kit (Quiagen, Hilden Germany) according to the
Figure 2. Transfection of the recombinant in HaCaT cells. Dishes
(10 cm) of HaCaT cells were grown to 80% confluence in DMEM and
transfected with 20 µg of recombinant DNA as described (Nead and
McCance, 1995). In parallel, control dishes were transfected with a
recombinant plasmid containing the LacZ gene under the control of the
CMV promoter. After 48 h, extracts were prepared and the β-galactosidase
activity was measured using CPRG as chromogen. The values of the
CMV-LacZ (lane 4) were taken as 100% and the activity of the URR-
LacZ recombinant (lane 3) was calculated accordingly. Lane 1 represents a
water control and lane 2 is the β-galactosidase activity of cell extracts
transfected with a promoterless LacZ gene.
manufacturers instructions. Reverse transcriptase–polymerase chain reaction
(PCR) was performed with the Access RT–PCR System (Promega). The
forward and reverse PCR primers used were 3470GAGATTGGCGTAA-
GTGAAGC3490 and 3989GTTGACTGTAGCGGCTGATG3970, respect-
ively. The size of the expected amplification product was 520 bp.
RESULTS
Expression of the transgene in transfected human epithelial
cells To test whether or not the HPV11-URR construct is active
in transcription, human HaCaT cells were transiently transfected
with the recombinant HPV11-URR/β-gal plasmid (see Materials
and Methods and Fig 1) and the amount of expressed β-galactosidase
was calculated. HaCaT is an immortal keratinocyte cell line isolated
from adult skin. As shown in Fig 2, the HPV-URR was indeed
able to drive transcription of the reporter gene in HaCaT cells,
albeit at a low level when compared with recombinants carrying
the CMV promoter. Thus, the HPV11-URR construct was used
to generate transgenic mice.
Generation of transgenic animals For the generation of the
transgenic mice, the HPV11-URR/β-gal NotI/ApaI fragment was
isolated from the vector (see Fig 1), purified and microinjected
into pronuclei. From a total of 150 embryos microinjected, 80
were implanted into foster mothers and a total of 14 transgenic
animals were obtained. Four lines (1697, 1702, 1704, and 1747)
were used for further analysis, because these mice were able to
express the transgene in vivo and to transmit it to their offsprings.
The other 10 founder lines did not express the transgene or did
not transmit it to their offspring properly. DNA isolated from these
animals was restriction cut with different enzymes and the relative
number of incorporated transgene copies determined. As shown in
Fig 3, three of the lines (1697, 1704, and 1747) contained a similar
number of copies, whereas a fourth one (line 1702) carried five to
10 times more copies. Using the corresponding standards we
calculated for the first three lines a number of less than 20 copies
per haploid genome. In addition, further restriction analyses of the
DNA demonstrated a head-to-tail concatemeric structure of the
integrated copies (not shown). Transgene line 1755 was not analyzed
further as the transgene was not transmitted properly during
subsequent breeding.
Expression of the transgene To analyze whether the HPV11-
URR was able to support expression of the transgene in skin
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Figure 3. Southern blot analysis of the founders 1697, 1702, 1704,
and 1747. Mouse tail DNA (10 µg) was digested with EcoRV, separated
on 0.7% agarose gels, blotted on to nylon membranes, and hybridized with
a radioactive labeled URR-LacZ DNA probe. Three fragments of a length
of 0.99, 1.5, and 2.4 kb were obtained, corresponding to the fragments
appearing after digestion of the original recombinant with EcoRV. This
pattern, together with results from other digestions, suggests a head-to-tail
organization of the recombinant DNA into the transgenic mouse genome.
epithelia, RNA from the skin of different transgenic mice was
isolated and reverse transcriptase–PCR was performed using the
primers described in Materials and Methods. Indeed a fragment of
the expected size, 520 base pairs, was amplified (Fig 4) and no
amplified fragment was observed in the reaction performed without
reverse transcriptase, demonstrating that the amplified band obtained
did not originate from contaminating DNA. Interestingly, although
the reverse transcriptase–PCR methodology used does not allow
accurate transcript quantitation, the similar intensity of the amplified
bands shown in Fig 4 suggests that transcription of the transgene
was similar in all animals tested.
Expression of β-galactosidase was analyzed in frozen sections of
various tissues isolated from the founder lines 1697, 1702, 1704,
and 1747, by histochemical staining with X-Gal. No expression of
the transgene was detected in any of the analyzed tissues or organs
known to harbour papillomaviruses in human lesions, such as
uterus, cervix, esophagus, tongue, vagina, testis, and penis, or in
those tissues known to be free of viral infection, such as stomach,
spleen, liver, kidney, ovary, and brain (data not shown). Surprisingly,
strong expression was found in the bulge region of the hair follicles.
In most of the slides, staining was confined to the epithelial cells
located between the sebaceous gland and the outer root sheath of
the hair (Figs 5B and 6B). In some sections, a slight pale blue
staining was found distributed evenly over the sebaceous gland,
but we interpret this as the result of X-Gal diffusion from the
Figure 4. Reverse transcriptase–PCR analysis of skin mRNA. RNA
was extracted from skin of the transgenic lines 1697 (lanes 1 and 2) 1704
(lanes 3 and 4), and 1747 (lanes 5 and 6). In lanes 1, 3, and 5, reverse
transcriptase was omitted. Lanes 7–9 show PCR products using different
amounts of the starting recombinant DNA as template. Lanes 10 and
11 are negative controls without RNA and without Taq polymerase,
respectively.
Figure 5. Histochemical detection of b-galactosidase in the skin of
the transgenic mice. Cryosections 8 µm thick of the dorsal skin of
transgenic mice were prepared, fixed and stained with X-Gal overnight.
Slides were counterstained with hematoxylin–eosin. (A) skin of a mouse
unable to transmit the transgene; (B) skin of a mouse of the transgenic
line 1704.
neighboring cells during the staining procedure (see next paragraph).
No staining was observed in control animals nor in animals shown
not to transmit the transgene to their offsprings (Figs 5A, top panel
and 6A). Furthermore, expression was limited to a fraction of the
total number of follicles, varying between 7 and 14% in the different
transgenic lines obtained.
To analyze whether expression of the transgene was develop-
mentally regulated, complete embryo sections were prepared from
embryos between days E12 and E19. No X-Gal staining was
detected in any of the transgenic lines at any of the embryonic
stages investigated (Fig 6C and data not shown). LacZ staining was
first found in 18 d old adults, at which time the growth of hair
still occurs synchronously (Handjisky et al, 1994). In addition, the
expression of the transgene in the adults was independent of age
and sex during the subsequent 2 y period of observation. The fact
that the expression of the transgene in all four founder lines showed
the same pattern of expression would indicate that the expression
was HPV11-URR specific and not due to a position effect of the
integrated transgene in the host genome.
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Figure 6. Characterization of X-Gal staining cells. Cryosections were
prepared and stained as described in Fig 5. (A) Staining of the dorsal skin
of a male (line 1775, nontransgenic) showing no X-Gal stain. (B) Skin of
a 2 mo old transgenic male (line 1697) showing staining over the hair
bulge region. (C) skin of an embryo at day 19 of embryogenesis. (D) X-
Gal staining of the skin of a mouse (line 1697) after application of
proteolytic enzymes by iontophoresis. Magnification, 3 450.
Localization of transgene expression As described above, the
reporter gene is only expressed in cells of the hair follicles leaving
the interfollicular epidermis free of staining. This is extremely
interesting as it has been suggested that the stem cells of the skin
are localized to this region and that, these cells are responsible for
hair growth as well as for the regeneration of the interfollicular
epithelium. Immunofluorescence studies, using β-galactosidase and
keratin 19 antibodies, thought to be specific for the putative
stem cells (Michel et al, 1996), prove inconclusive. We therefore
attempted to further characterize the expressing cells type by the
iontophoretic protocol (Protopapa, 1997).
The proteases papain and chymotrypsin are transported by
iontophoresis or by liposomes into the hair bulge. The action of
these enzymes leads to the destruction of the intercellular keratino-
cyte structure in the stratum spinosum resulting in a withdrawal of
the keratin layer from the stratum granulosum and in the proteolysis
of epithelial stem cells. In contrast, the cells of the sebaceous glands
remain protected from the exogenous protease activity by the
secreted sebum (Protopapa, 1997). Thus, in the case of an expression
of the reporter gene in epithelial cells, one would expect a
change in X-Gal staining localization following treatment with
chymotrypsin and papain. Whereas in the case of expression of the
reporter gene in the cells of the sebaceous gland, one would expect
the protease treatment to have no influence on the X-Gal staining.
As shown in Fig 6(D), following chymotrypsin and papain treat-
ment, the β-galactosidase activity was detected only in the lumen
of the hair follicle and no longer in its previous place (Fig 6B).
We therefore conclude that expression of the transgene takes place
preferentially, if not exclusively, in the epithelial cells surrounding
the upper part of the sebaceous gland.
Transcriptional control of the transgene in vivo The URR
of the HPV11, as used for the generation of the transgenic animals,
contains putative GRE and AP-1 motifs suggesting that promoter
activity can be controlled by corticoids or agents regulating activity
of the AP-1 protein, such as phorbol esters or UV light. Thus,
transgenic animals were topically treated either with dexamethasone
or with phorbol myristate acetate (PMA), and the number of hair
follicles expressing the transgene at different times after application
was calculated. Whereas dexamethasone elicited an increase in the
number of positive follicles 6 h after application, no effect was
observed in PMA-treated animals (Fig 7 and data not shown).
Further, the increase in LacZ expression in dexamethasone-treated
animals disappears 24 h after treatment (Fig 7). Thus dexamethasone
appears to modulate transcription of the gene in a precise manner,
similar to that described for mice carrying the HPV18 URR region
Figure 7. Time course of dexamethasone treatment. Dexamethasone
was applied on to the back of transgenic mice (lines 1704 and 1742). The
solvent acetone was applied elsewhere on the same animals as negative
control. The animals were killed 0, 6, 24, 48, and 72 h later cryosections
were stained with X-Gal staining. The percentage of stained hair follicles
out of all hair follicles is shown. The values for acetone-treated animals
are shown in open bars, those for transgenic animals in black bars.
Quantitation was performed as described in Materials and Methods.
Figure 8. Time course of UVB treatment. Transgenic animals (the
same lines as in Fig 6) were irradiated at the doses described in Materials
and Methods. Controls were biopsies of the same animals from skin parts
covered during irradiation. The animals were killed 0, 8, 16, 24, and 48 h
after irradiation and cryosections were prepared from the skin and stained
with X-Gal. The percentage of stained hair follicles out of all hair follicles
is shown. The open bars show the values for untreated animals; UVB-
treated transgenic mice are shown in black bars.
cloned in front of the LacZ coding sequence (Cid et al, 1993). In
addition, treatment of the animals with 0.5 mg progesterone did
not result in any change in number or intensity of stained hair
follicles (data not shown), in accordance with the observation that
expression of the transgene was sex- and estrus-independent.
The UVB radiation experiments showed no change in the
expression pattern until 48 h after irradiation. At 48 h after
irradiation a strong increase in the number of LacZ-positive follicles
was observed (Fig 8). We also noticed that, at this time there was
an observable increase in expression of the transgene in the
follicles, based on optical observation of the stained slides (a precise
quantitation of the β-galactosidase was not possible for technical
reasons). At 72 h after irradiation, staining declined to values similar
to the 24 h time-point. Thus, dexamethasone and UVB are able
to modulate the transcriptional characteristics of the HPV11-URR
under in vivo conditions.
DISCUSSION
We have generated transgenic mice carrying the URR of the low-
risk type HPV11 in front of the β-galactosidase as a reporter gene
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and have analyzed the transcriptional characteristics of the transgene.
Four founder lines were found to express the transgene and to
transmit it to their descendants, three of which possessed a similar
number of integrated copies and transcribed the gene to similar
levels.
The finding that our transgenic mice expressed the transgene
exclusively in the hair follicles was unexpected. No LacZ staining
was observed in those tissues known to be a target for HPV11
infection, nor in other tissues refractory to viral infection. These
results sharply contrast with those obtained when the HPV18-
URR was used for the generation of transgenic mice (Choo et al,
1992; Cid et al, 1993; Chen et al, 1995). Although contradictory
results have been published, LacZ expression in HPV18-URR
transgenic mice appears to be either limited to the epithelial cells
or widely distributed among all organs (Cid et al, 1993; Michelin
et al, 1997). The reasons for the differences between types 11 and
18 are unknown. These differences cannot rely in the use of
different mice strains to produce the transgenic animals, as in both
experiments the same strain, as well as the same starting reporter
plasmid, were used. Furthermore, although the URR of both types
are similar (both contain putative binding motifs for AP-1, SP1,
NF1, or C/EBPβ), and both viruses replicate in human epithelial
cells, slight differences in the redundancy or activity of some
elements might be responsible for the differences in specificity
observed (Morris et al, 1993). In addition, mechanisms linked to
the natural state of the virus (predominantly episomal in the case
of HPV11 or integrated in the case of HPV18) may further play a
part in establishing cell specificity and transcriptional efficiency.
Whereas, in humans HPV11 expression is found preferentially
in interfollicular keratinocytes, in mice LacZ staining is localized
exclusively to the hair epithelium. The reasons for this difference
are unknown but it may well be that human keratinocytes contain
all the specific factors necessary to complete HPV11-specific
transcription, factors which would be absent in mouse interfollicular
epithelium. Histologic examination of skin sections of the transgenic
mice allowed the localization of the β-galactosidase expression to
the epithelial cells associated with the sebaceous glands. The light
blue color sometimes observed in the glandular cells was interpreted
to be due to color diffusion from the epithelial cells during X-Gal
staining. This assumption is based on several facts: we always found
clear staining in the epithelial cells and only a pale bluish staining
in the sebaceous glands. Further, the iontophoretic experiments
demonstrate that the X-Gal staining, remaining after treatment, is
exclusively found in the interior of the hair follicle and not in the
position corresponding to the sebaceous glands. This is the position
the remaining bulge cells adopt after papain/chymotrypsin treatment
of the skin by iontophoresis (Protopapa, 1997).
It is interesting to note that the epithelial bulge cells are probably
the primary target cells of papillomavirus infection in cottontail
rabbits (Schmitt et al, 1996). There is evidence that HPV persists
in hair follicles, although the biologic significance of this finding,
as well as the precise localization are currently unknown (J. ter
Schegget, personal communication and our unpublished results). It
remains open as to whether the cells expressing the transgene in
our animals correspond to those cells found to harbor HPV
sequences in human infections or if the cells are intact skin stem
cells. In any case, we did not unequivocally observe the presence
of keratin 19 (a potential marker for keratinocytes stem cells,
Michel et al, 1996) in the β-galactosidase positive cells. Further,
low-risk and high-risk HPV sequences have also been found in
sebaceous gland carcinomas of the eyelid and vagina but not in
normal keratinocytes (Hayashi et al, 1994; Carlson et al, 1996). In
this context it is interesting that mouse skin develops more
tumors when the carcinogen is applied during early anagen phase,
implicating therefore the bulge cells as potential precursors of some
skin tumors (Miller et al, 1993). Thus, we believe that our
transgenic animals express the transgene solely in the epithelial cells
surrounding the sebaceous gland of the hair and that this expression
can be regulated by external stimuli.
Expression from the URR appears to be developmentally
regulated, as no LacZ staining was found in embryos, even at day
18 of pregnancy, when the hair structure is already well developed.
It is noteworthy that in juvenile mice a stronger expression of the
transgene was observed, perhaps depending on the hair growth
phase at this age (Miller et al, 1993). This, and the fact that all
other organs analyzed in adults were negative, suggests a tight
regulation of the URR by factors present only in the keratinocytes
of the hair follicle. These factors presumably confer cell specificity
to the transgene. In HPV11 it seems well established that the CEI
region of the URR is responsible for cell specificity in in vitro
transfection experiments (Dollard et al, 1993).
Although little is known about the mechanisms responsible for
HPV specific gene expression, it would appear that these mechan-
isms are related to transcription rather than to infection. The
description of a putative HPV receptor in several cell types, some
of them of nonepithelial origin, supports this possibility (Evander
et al, 1997). As HPV is mainly found as an episome in infected
cells, it is possible that tight regulation is accounted for by
mechanisms related to the episomal stage and that upon integration
into the host genome these mechanisms are totally or partially
abolished. In any case, it seems that viral integration, at least HPV16
in SiHa cells, does not instigate large chromatin rearrangements at
the integration locus (Bauer-Hofmann et al, 1996).
The regulatory properties of the URR appear to be conserved
after incorporation into the mouse genome, as treatment with
dexamethasone or UVB clearly modulate gene expression (see
Results). In both HPV18-URR and HPV11-URR transgenic mice,
treatment with dexamethasone triggers increased expression of the
LacZ gene in the expressing tissues. In both cases increased
expression occurs 6 h after treatment, suggesting that the mechan-
isms responsible for modulation are similar in both HPV types.
Interestingly, the tumor promoter PMA fails to modulate tran-
scription via the URR. Our results show that, even 48 h after
treatment, no increase in X-Gal staining could be observed. This
is in contrast to the increase observed after irradiation with UVB
light. As both PMA and UVB probably function by increasing
transcription of the AP-1 genes, one might expect that both agents
would produce a similar increase in transgene transcription. This
was clearly not the case in our experiments. Interestingly, we found
a large increase in the amount of AP-1 protein 48 h after skin
irradiation of our transgenic animals, declining thereafter (our
unpublished results). These results are in agreement with those
published before, which also described an increased AP-1 expression
in transgenic mice after UVB treatment (Huang et al, 1997). Thus
it seems that protein kinase C activation by PMA and subsequent
transcription of AP-1 proteins are not enough to modulate activation
of the HPV11 promoter, and that other, additional effects are
necessary to activate in vivo transcription of the HPV11-URR.
Taken together, our results demonstrate that, in our transgenic
animals, HPV11-URR drives transcription exclusively in the epi-
thelial cells associated with the sebaceous glands and that this
transcription is tightly regulated. The use of the promoter region
described here in conjunction with genes potentially involved in
epithelial proliferation/differentiation should provide an invaluable
tool for the analysis of hair development.
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